Articles

Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, UK
Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany;Oslo Center for Biostatistics and Epidemiology; Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway
Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, UK
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Molecular Therapy in Haematology and Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), and Department of Medicine V, University Hospital Heidelberg, Germany
Internal Medicine III, University of Ulm, Germany
Division of Immunogenetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Division of Immunogenetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, UK
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Vol. 103 No. 4 (2018): April, 2018 https://doi.org/10.3324/haematol.2017.177808